Pharmaceutical
+243
Oncology (2025 Update)
Novel approaches to oncology are prominent, from AI-driven drug discovery and radioligand therapies to precision medicine and immunomodulatory antibodies. These companies aim to improve patient outcomes in cancer and leukemia treatments.
👋🏼 Hey there! Bounce Watch here — I'm gathering key information from Oncology list.
Real-Time Scouting Assistant
5 highlights have been identified across this list.
Mentioned on News
1
Open Positions
4
Latest Highlights
Explore Oncology featuring 250 Companies in Pharmaceutical Industry
|
|
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
Click Therapeutics, Inc. | - | - | Click Therapeutics, Inc., develops, validates, and commercializes software as pr... | - |
United States
|
New York | United States (HQ) | 2012 | Biotechnology, Health Care +3 | [email protected] |
1
Low
|
186
|
13.0K (-10%) | 1 year ago | Debt Financing | 12 | 946.4M | 18742 | 4 months ago | |
|
|
|
ROME Therapeutics | - | Harnessing the power of the repeatome to develop a new class of therapies for ca... | ROME Therapeutics is developing novel therapies for cancer and autoimmune diseas... | - |
United States
|
Boston | United States (HQ) | 2020 | Biotechnology, Health Care +1 | - |
1
Low
|
49
|
3.2K (60%) | 1 year ago | Series B | 3 | 199.0M | 9662 | 4 months ago | |
|
|
|
OnCusp Therapeutics | - | We Bring Oncology Innovation to Life | OnCusp Therapeutics, Inc., headquartered in New York City, is a biopharmaceutica... | - |
United States
|
New York | United States (HQ) + 1 | 2021 | Biotechnology, Health Care +1 | - |
1
Low
|
20
|
29 (-100%) | 1 year ago | Series A | 2 | 125.0M | 1737 | 1 year ago | |
|
|
|
Janux Therapeutics | - | - | Janux is a clinical-stage company developing unique immunotherapies that have th... | - |
United States
|
San Diego | United States (HQ) | 2017 | Biotechnology, Health Care +2 | - |
1
Low
|
78
|
3.1K (29%) | 1 year ago | Post Ipo Equity | 5 | 548.9M | 6949 | 4 months ago | |
|
|
|
AMW GmbH | - | Controlled drug delivery for superior treatment. For patients, worldwide. |
Controlled drug delivery for superior treatment. For patients, worldwide. AMW’s... |
- |
Germany
|
- | Germany (HQ) | 2008 | Health Care, Medical Devices +1 | [email protected] |
1
Low
|
69
|
996 (-29%) | 7 years ago | Series Unknown | 3 | 38.0M | 1238 | 4 months ago | |
|
|
|
Simcha Therapeutics | - | Overcoming biological challenges in clinically translatable pathways. | Simcha Therapeutics is a clinical-stage immunobiology company pioneering the dev... | - |
United States
|
New Haven | United States (HQ) | 2018 | Biotechnology, Health and Wellness +2 | [email protected] |
1
Low
|
15
|
959 (-100%) | 3 years ago | Series B | 2 | 65.0M | 1342 | 5 months ago | |
|
|
|
Aston Sci. | - | Empowering Patients with Innovative Cancer Immunotherapy | Aston Sci. is a clinical-stage biopharmaceutical company that is currently focus... | - |
Korea South
|
- | Korea South (HQ) + 2 | 2018 | Biotechnology, Pharmaceutical | - |
1
Low
|
8
|
66 | 4 years ago | Series C | 1 | 27.0B | 1005 | 1 year ago | |
|
|
|
tranScrip | - | A specialist pharmaceutical consultancy providing strategic, therapeutic and ope... | tranScrip is a highly specialist pharmaceutical consultancy providing strategic... | - |
United Kingdom
|
Wokingham | United Kingdom (HQ) + 2 | 2008 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
95
|
3.4K (424%) | 4 years ago | Private Equity | 1 | Unknown | 5032 | 4 months ago | |
|
|
|
Aurealis Therapeutics | - | Multi-target cell and gene therapies for unmet medical needs. | Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company.... | - |
Finland
|
- | Finland (HQ) + 1 | 2015 | Biotechnology, Health and Wellness +1 | - |
1
Low
|
17
|
923 (37%) | 2 years ago | Series A | 1 | 10.0M | 2343 | 4 months ago | |
|
|
|
Regor Therapeutics Group | - | We aspire to be a world class innovative drug discovery company from China. | Regor Therapeutics is a clinical stage company dedicated to the discovery and de... | - |
China
|
Shanghai | China (HQ) + 1 | 2018 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
29
|
1.4K (49%) | 3 years ago | Series Unknown | 3 | 140.0M | 1052 | 6 months ago | |
|
|
|
MGC Pharmaceuticals | - | Global next-generation Pharma licensed company. Improving lives with innovative... | MGC Pharmaceuticals Limited ("MGC") (MXC: LSE, ASX) is a next-generation Pharma... | - |
United Kingdom
|
London | United Kingdom (HQ) | 2005 | Pharmaceutical, Wellness Beauty | [email protected] |
1
Low
|
37
|
492 | 1 year ago | Post Ipo Equity | 5 | 19.7M | 6153 | 1 year ago | |
|
|
|
Convalife Pharmaceuticals | - | Pioneering the future of tumor disease treatment through advanced pharmaceutical... | Convalife Pharmaceuticals is an innovative pharmaceutical company that specializ... | - | - | - | - | 2018 | Biopharma, Pharmaceutical | [email protected] |
1
Low
|
835
|
462 | 1 year ago | Series C | 2 | 200.0M | 7923 | 1 k9Y WFp | |
|
|
|
Beihai Biotech | - | Putting Patients First, Innovation for All | Beihai Biotech is a leading biopharmaceutical company dedicated to revolutionizi... | - | - | - | - | 2008 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
1
|
872 (-100%) | 1 year ago | Series C | 4 | 300.0M | 10500 | 10 Gf1 f9p | |
|
|
|
RIEMSER Pharma | Not active anymore | Pioneering specialized pharmaceuticals in oncology, anti-infectives, and dermato... | RIEMSER Pharma GmbH, previously known as RIEMSER Arzneimittel AG, is an internat... | - | - | - | - | 1990 | Biotechnology, Health Care +1 | - |
-1
N/A
|
233
|
703 | 17 years ago | Series Unknown | 2 | Unknown | 68026 | 9 CJM GR0 | |
|
|
|
HDT Bio | - | Immune Therapy For All | HDT Bio is a vaccine and immunotherapy Biotechnology company developing drugs fo... | - |
United States
|
Seattle | United States (HQ) | 2018 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
58
|
2.9K (26%) | 1 year ago | Grant | 7 | 70.0M | 5663 | 5 months ago | |
|
|
|
Polymed Biopharmaceutical... | - | Polymed creates novel PROTAC therapies for cancers and immunology HPB-143 (IRA... | At Polymed, we focus on novel protein degrader therapies in the areas of oncolog... | - |
China
|
Hangzhou | China (HQ) + 1 | 2019 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
2
|
81 (-88%) | 2 years ago | Series A | 1 | Unknown | 65 | 4 months ago | |
|
|
|
Molecular Partners | - | Pioneering DARPin Therapeutics for Patients | Molecular Partners AG is a clinical-stage biotech company pioneering the design... | - |
Switzerland
|
- | Switzerland (HQ) + 1 | 2004 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
174
|
2.7K (-43%) | 4 years ago | Post Ipo Equity | 4 | 188.8M | 10893 | 4 months ago | |
|
|
|
BioDlink(TOT BIOPHARM) | - | Empowering Pharmaceutical Innovation, Improving Quality of Life, Safeguarding Hu... | BioDlink(TOT BIOPHARM) is dedicated to becoming the industry leading and trusted... | - |
China
|
- | China (HQ) | 2009 | Biopharma, Biotechnology +2 | - |
1
Low
|
80
|
455 (-2%) | 6 years ago | Series B | 2 | 108.0M | 389 | 4 months ago | |
|
|
|
Jounce Therapeutics, Inc. | - | Daring to create a world immune to cancer. | Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to... | - |
United States
|
Cambridge | United States (HQ) | 2013 | Biotechnology, Health and Wellness +1 | - |
1
Low
|
18
|
272 | 4 years ago | Post Ipo Equity | 4 | 194.2M | 12700 | 8 z9p 0eN | |
|
|
|
OncXerna Therapeutics | - | Advancing a new paradigm of precision oncology with a RNA-based approach to matc... | OncXerna Therapeutics is a clinical stage precision medicine oncology company de... | - |
United States
|
Waltham | United States (HQ) | 2018 | Biopharma, Biotechnology +3 | - |
1
Low
|
8
|
1.1K (87%) | 3 years ago | Series Unknown | 3 | 126.5M | 1638 | 4 zuI G9k | |
|
|
|
TME Pharma | - | Developing novel therapies for treatment of the most aggressive cancers by actin... | TME Pharma is a clinical-stage company focusing on developing novel therapies fo... | - |
Germany
|
Berlin | Germany (HQ) | 1998 | Biotechnology, Health Care +1 | - |
1
Low
|
20
|
741 (-100%) | 11 months ago | Post Ipo Equity | 13 | 138.7M | 3925 | 4 months ago | |
|
|
|
Aegera Therapeutics Inc. | Not active anymore | - | Aegera Therapeutics is a clinical stage biotechnology company focused on develop... | - | - | - | - | 1997 | Biotechnology, Health Care +1 | - |
-1
N/A
|
6
|
55 | 15 years ago | Debt Financing | 3 | 35.6M | 96933 | 5 rg5 Qrw | |
|
|
|
Oncostellae | - | Novel small-molecule drugs in immunology, fibrosis and women health | Clinical-stage biotech company founded by serial entrepreneurs and owned by priv... | - |
Spain
|
- | Spain (HQ) + 1 | 2013 | Health Care, Pharmaceutical | [email protected] |
1
Low
|
10
|
596 (-100%) | 1 year ago | Series A | 4 | 4.4M | 1454 | 7 wu1 axm | |
|
|
|
Rgenta Therapeutics Inc. | - | We unlock the therapeutic potentials of highly disease-relevant targets undrugga... | Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeti... | - |
United States
|
Woburn | United States (HQ) + 1 | 2020 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
29
|
1.9K (1567%) | 2 years ago | Series A | 6 | 116.9M | 5006 | 4 months ago | |
|
|
|
Redx Pharma | - | Biotech company focusing on the discovery and development of novel targeted medi... | Redx Pharma is a clinical-stage biotechnology company focused on the discovery a... | - |
United Kingdom
|
- | United Kingdom (HQ) | 2010 | Biotechnology, Health Care +1 | - |
1
Low
|
76
|
6.1K (30%) | 3 years ago | Post Ipo Equity | 8 | 103.1M | 11570 | 1 year ago | |
|
|
|
Oncomedics | - | 1 patient - 1 tumour - 1 Oncogramme® - 1 treatment | Oncomedics is a biotechnology company, part of CliniSciences Group, specializing... | - | - | - | - | 2006 | Biotechnology, Pharmaceutical | - |
1
Low
|
11
|
191 (-100%) | 7 years ago | Angel | 1 | Unknown | 6577 | 5 months ago | |
|
|
|
Humanetics Corporation | - | Preventing Radiation Damage | Humanetics is a privately held, clinical stage pharmaceutical company located in... | - |
United States
|
Minneapolis | United States (HQ) | 1988 | Biotechnology, Pharmaceutical | - |
1
Low
|
17
|
1.3K (-24%) | 1 year ago | Grant | 5 | 9.2M | 630 | 5 months ago | |
|
|
|
Symphogen | - | - | Symphogen A/S, a Servier company and the Centre of Excellence for Antibodies, op... | - |
Denmark
|
- | Denmark (HQ) + 1 | 2000 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
188
|
363 (-100%) | 9 years ago | Debt Financing | 10 | 375.2M | 12386 | 4 months ago | |
|
|
|
Marina Biotech, Inc. | Not active anymore | - | Marina Biotech’s focus is to treat the intersection of arthritis, pain, hyperten... | - |
United States
|
City Of Industry | United States (HQ) | 1983 | Biotechnology, Health Care +1 | [email protected] |
-1
N/A
|
11
|
200 | 6 years ago | Post Ipo Equity | 7 | 24.9M | 1466 | 6 NeI ddH | |
|
|
|
QuantHealth | - | Accelerating drug development with AI-driven patient-centric medication simulati... | QuantHealth is a company that develops artificial intelligence-based software fo... | - | - | - | - | 2020 | AI, Pharmaceutical | [email protected] |
1
Low
|
227
|
1.2K (-14%) | 1 year ago | Series A | 3 | 17.0M | 2743 | 11 months ago | |
|
|
|
Camino Pharma, LLC | - | - | Camino Pharma is a San Diego-based startup company focused on discovering and de... | - |
United States
|
San Diego | United States (HQ) | 2014 | Health Care, Pharmaceutical | [email protected] |
1
Low
|
3
|
1.4K (60%) | 1 year ago | Grant | 3 | 13.7M | 205 | 10 StZ xOy | |
|
|
|
BiPER Therapeutics | - | First in class small molecules pushing cancer cells to burn out | BiPER Therapeutics is developing a first-in-class pipeline of therapeutics overs... | - |
France
|
- | France (HQ) | 2021 | Biotechnology, Health and Wellness +1 | [email protected] |
1
Low
|
7
|
756 (-24%) | 2 years ago | Debt Financing | 3 | 1.3M | 1345 | 4 months ago | |
|
|
|
Theratechnologies Inc. | - | Health innovation that matters | #HIV #NASH #Oncology | Theratechnologies is a clinical-stage biopharmaceutical company focused on the d... | - |
Canada
|
Montreal | Canada (HQ) + 1 | 1993 | Biotechnology, Pharmaceutical | - |
1
Low
|
98
|
6.0K (18%) | 1 year ago | Post Ipo Equity | 6 | 199.4M | 14038 | 4 months ago | |
|
|
|
Dracen Pharmaceuticals, I... | - | - | Private biotech company leveraging immuno-metabolism to create a potential new t... | - |
United States
|
New York | United States (HQ) + 1 | 2016 | Health Care, Pharmaceutical | [email protected] |
1
Low
|
5
|
1.0K (18%) | 1 year ago | Debt Financing | 3 | 50.9M | 397 | 1 year ago | |
|
|
|
Lisata Therapeutics, Inc. | - | Targeted Therapy Delivered | Lisata Therapeutics is a U.S. clinical-stage pharmaceutical company (Nasdaq: LST... | - |
United States
|
- | United States (HQ) | 2006 | Biotechnology, Health and Wellness +1 | - |
1
Low
|
42
|
4.1K (-2%) | 4 years ago | Grant | 11 | 165.6M | 4880 | 4 months ago | |
|
|
|
Lanthio Pharma | - | Biopharmaceutical company discovering and developing stabilized lanthipeptides i... | Welcome to Lanthio Pharma Lanthio Pharma is a Dutch biopharmaceutical company co... | - |
The Netherlands
|
- | The Netherlands (HQ) | 2010 | Biotechnology, Health and Wellness +1 | [email protected] |
1
Low
|
1
|
295 | 11 years ago | Debt Financing | 2 | 8.4M | 223 | 1 FnQ SaG | |
|
|
|
Beta Pharma, Inc. | - | - | Beta Pharma is an emerging specialty pharmaceutical company dedicated to the dis... | - |
United States
|
Princeton | United States (HQ) | 1996 | Biotechnology, Health Care +1 | - |
1
Low
|
35
|
1.1K (26%) | - | - | - | - | 1327 | 1 Ioj Iio | |
|
|
|
MEDRHANS PHARMACEUTICALS... | - | Care for Cure | MEDRHANS Pharmaceuticals Pvt Ltd. is a specialty pharmaceutical company engaged... | - |
India
|
Hyderabad | India (HQ) | 2018 | Manufacturing, Pharmaceutical | [email protected] |
1
Low
|
8
|
958 | - | - | - | - | 123 | 4 months ago | |
|
|
|
Rexahn Pharmaceuticals | Not active anymore | TARGETING DIFFICULT TO TREAT CANCERS | Rexahn Pharmaceuticals Inc. (NYSE American:RNN) is a clinical stage biopharmaceu... | - |
United States
|
Rockville | United States (HQ) | 2001 | Biotechnology, Medical Devices +1 | [email protected] |
-1
N/A
|
7
|
160 | 6 years ago | Post Ipo Equity | 2 | 13.6M | 2940 | 5 JDv ksR | |
|
|
|
Ipsen | - | - | We are a global biopharmaceutical company with a focus on bringing transformativ... | - |
France
|
- | France (HQ) + 49 | 2010 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
6066
|
104.8K | 7 years ago | Post Ipo Equity | 1 | 22.0M | 244489 | 4 months ago | |
|
|
|
NovaRx Corporation | - | - | Privately held biotechnology company committed to the developmentment of novel c... | - | - | - | - | 1997 | Biotechnology, Pharmaceutical | - |
1
Low
|
14
|
223 | - | - | - | - | 21753 | 8 jRC 68c | |
|
|
|
Trojan Bio | - | Harnessing viral specific immunity for fighting cancer | Trojan Bio is developing a novel class of therapeutic antibodies for the treatme... | - |
Israel
|
- | Israel (HQ) | 2021 | AI, Manufacturing +1 | - |
1
Low
|
8
|
615 | 3 years ago | Pre Seed | 1 | Unknown | 398 | 1 year ago |